倍他米松乳膏(利康达宁)的说明书

克霉唑倍他米松乳膏Kemeizuo Beitamisong RugaoClotrimazole and Betamethasone Dipropionate Cream本品含克霉唑(C22H17ClN2)与二丙酸倍他米松以倍他米松(C22H29FO5)计算，均应为标示量的90.0%～110.0%。

【处方】克霉唑 10g二丙酸倍他米松 0.643g（相当于倍他米松0.5g）基质适量全量 1000g【性状】本品为白色乳膏。

【鉴别】在含量测定项下记录的色谱图中，供试品溶液两主峰的保留时间应与对照品溶液中相应的两主峰的保留时间一致。

【检查】二苯基-(2-氯苯基)甲醇取本品适量(相当于克霉唑10mg)，精密称定，置50ml量瓶中，加甲醇28ml，置50℃水浴中加热，时时振摇使溶解，然后取出强烈振摇5分钟，加水12ml，摇匀，迅速冷至室温，用水-甲醇(3:7)稀释至刻度，摇匀，用0.45μm滤膜滤过，取续滤液作为供试品溶液；另取二苯基-(2-氯苯基)甲醇对照品，精密称定，用水-甲醇(3:7)稀释制成每1ml中含4μg的溶液，作为对照品溶液。

除检测波长为215nm外，照含量测定项下的色谱条件，精密量取对照品溶液与供试品溶液各10μl，分别注入液相色谱仪，记录色谱图至供试品溶液主成分峰保留时间的1.5倍，供试品溶液色谱图中如有与二苯基-(2-氯苯基)甲醇对照品溶液主峰保留时间相应的色谱峰，按外标法以峰面积计算，二苯基-(2-氯苯基)甲醇不得大于克霉唑标示量的2.0%。

其他应符合乳膏剂项下有关的各项规定（附录ⅠF）。

【含量测定】照高效液相色谱法(附录V D)测定。

色谱条件与系统适用性试验用十八烷基硅烷键合硅胶为填充剂；以0.05mol/L磷酸二氢钾溶液-甲醇(30:70，用10%磷酸调节pH值至5.7～5.8)为流动相；检测波长为240nm。

理论板数按克霉唑峰计算不低于4000，克霉唑峰、二丙酸倍他米松峰、二苯基-(2-氯苯基)甲醇峰和其它杂质峰之间的分离度均应符合要求。

常用外用乳膏简易说明书酞丁安乳膏:用于疱疹真菌感染体廯手足廯tid用于疱疹bid早晚用于真菌感染体股藓连用三周手足廯连用四周作用：抗真菌止痒孕妇忌用维胺酯维E乳膏：用于痤疮外用一日1到2次睡前用更佳。

作用：抗炎抑制痤疮抗氧化保护皮肤作用曲安奈德益康唑乳膏：用于皮炎湿疹手足廯甲沟炎早晚各一次皮炎湿疹疗程2-4周糖皮质激素类药物抗炎抗过敏止痒糠酸莫米松乳膏:用于湿疹神经性皮炎皮肤瘙痒症qd复方酮康唑软膏体癣股癣手足廯一日二次夫西地酸乳膏各种细菌性皮肤感染脓包病毛囊炎甲沟炎须疮汗腺炎红癣寻常痤疮创伤合并感染一日2---3次7天一疗程丁酸氢化可的松乳膏：过敏性皮炎脂溢性皮炎过敏性湿疹苔藓样瘙痒一日二次维A酸乳膏寻常痤疮扁平疣黏膜白斑毛发红糠疹毛走角化病及银屑病辅助治疗哺乳期妇女禁用怀孕初期3个月禁用眼部禁用水杨酸软膏用于头癣足癣及局部角质增生一日二次复方倍他米松樟脑乳膏（无极膏）消炎镇痛止痒局部麻醉作用虫咬皮炎丘疹性荨麻疹湿疹神经性皮炎皮肤瘙痒一日2--3次复方克霉唑乳膏接触性皮炎湿疹神经性皮炎伴细菌和真菌感染复方乳酸乳膏手足皲裂和鱼鳞病一日二次疗程4周盐酸特比萘芬乳膏手癣足癣体癣股癣花斑癣及念珠菌病一日二次疗程1-2周复方樟脑乳膏虫咬皮炎过敏性皮炎丘疹性皮炎丘疹性荨麻疹湿疹瘙痒症神经性皮炎一日2--3次糠酸莫米松乳膏湿疹神经性皮炎异位性皮炎皮肤瘙痒一日一次阿昔洛韦乳膏单纯性或带状性疱疹一日4--6次共7日力康霜（中药沙棘油芦荟VE B6）杀菌止痒五妙水仙膏（中药黄柏、紫草五倍子生石灰）去腐生新清热解毒毛囊炎结节性痒疹寻常疣神经性皮炎林可霉素利多卡因凝胶轻度烧伤创伤及蚊虫叮咬引起的各种皮肤感染一日2--3次地奈德乳膏抹面霜那样，随意凭感觉。

也不可以觉得激素有副作用，只涂一点点。

正确的做法是：用指尖单位（FTU）来涂抹外用激素药膏。

在《规范外用糖皮质激素类药物专家共识》中指出：制药厂生产的标准药膏管均为5mm内径，将药膏挤在成人食指最末一个指节，大约为0.5g，就是1FTU，可以在成人两个手掌的面积均匀涂抹一层（如下图所示）。

倍他米松新霉素乳膏(联邦倍新)的说明书随着皮肤病越来越高的发病率，很多患者也开始重视起来，纷纷寻找最好的治疗方法和治疗药物，但是很多患者在众多药物中却不知作何选择。

倍他米松新霉素乳膏(联邦倍新)在众多治疗皮肤病的药物中是效果最好的一种，到底倍他米松新霉素乳膏(联邦倍新)又怎样的功效呢，我们看下边的详细介绍。

【药品名称】通用名称：倍他米松新霉素乳膏商品名称：倍他米松新霉素乳膏(联邦倍新)拼音全码：BeiTaMiSongXinMeiSuRuGao(LianBangBeiXin)【主要成份】复方制剂，其组分为每克含倍他米松戊酸酯以倍他米松计为1毫克及硫酸新霉素3500单位。

【性状】本品为类白色乳膏。

【适应症/功能主治】用于治疗接触性皮炎、过敏性皮炎及各型湿疹等皮肤病。

【规格型号】15g【用法用量】外用，涂擦于患处，一天2次。

连续使用本品不宜超过2周。

【不良反应】报道和外用肾上腺皮质激素有关的局部副作用尤其是封闭式地敷药时，包括：灼烧感，痒，刺痛，干燥，多毛，突发粉刺，色素沉着，口周围皮炎，过敏性接触性皮炎，皮肤浸润，继发性感染，皮肤萎缩，痱子等。

和外用新霉素有关的耳毒性、肾毒性、过敏反应也有报道。

【禁忌】禁用于对本品任何组分有过敏史的病人。

【注意事项】用皮质激素可能发生任何系统使用皮质激素包括肾上腺抑制剂时发生的副作用，尤其是婴儿和儿童使用时。

大面积外用或封闭式涂敷可导致皮质激素或新霉素全身性吸收。

避免将新霉素用于开放性伤口或损伤的皮肤。

婴儿和儿童或长时间使用时更应注意。

延长外用抗生素的使用可能导致非敏感细菌的过度生长，包括真菌。

如果发生刺激、过敏或深度感染应停药并治疗。

本药不能用于眼睛。

慎用于面部、皮肤褶皱部位如腋下、腹股沟等。

【儿童用药】尚不明确。

【老年患者用药】尚不明确。

【孕妇及哺乳期妇女用药】孕妇使用本品的安全性尚未确立，故不能长期大量用于孕妇。

哺乳期妇女慎用。

【药物相互作用】尚不明确。

【药物过量】症状：长期外用皮质激素可抑制垂体-肾上腺功能继发性肾上腺功能减退。

目录1.丁苯羟酸乳膏12.地奈德乳膏33.复方氟米松软膏54.卤米松乳膏说明书75.雌三醇乳膏96.卡泊三醇软膏117.曲咪新乳膏138.维胺酯维E乳膏149.他扎罗汀乳膏1510.莫匹罗星软膏2011.盐酸特比萘芬2112.肝素钠乳膏说明书2313.喷昔洛韦乳膏说明书2414.维A酸软膏2515复方多粘菌素B软膏2716硝酸舍他康唑软膏29丁苯羟酸乳膏其化学名：4－丁氧基－N－羟基苯乙酰胺。

[结构式][性状]本品为白色乳膏。

[药理、毒理]本品为非甾体抗炎药物。

局部皮肤外用对角叉菜胶致大鼠足趾肿胀和二甲苯致小鼠耳廓肿胀具有抑制作用。

[药代动力学]皮肤局部使用后进入体循环的药物很少，在局部皮肤组织可达到较高药物浓度。

[适应症]本品适用于湿疹、神经性皮炎。

[用法与用量]本品适量涂于患处，每日2~4次；或遵医嘱。

[不良反应]（1）过敏反应，表现为局部发红、丘疹、水肿、肿胀、小水疱等。

（2）有局部刺激作用，长期使用，可有皮肤色素沉着。

[禁忌症]对本品过敏者禁用。

[注意事项]（1）发生过敏反应立即停药。

（2）本品不能用于眼科。

（3）药品性状发生改变时禁用。

（4）儿童必须在成人监护下使用。

（5）请将此药品放在儿童不能接触的地方。

[规格]（1）10g:0.5g；（2）15g:0.75g[贮藏]密封，置阴凉干燥处保存。

[关联疾病]紫斑湿疹综合征维斯科特-奥尔德里奇综合征婴儿湿疹神经性皮炎渗出性神经性皮炎外阴神经性皮炎地奈德乳膏[主要成分]本品主要成份为地奈德，其化学名称为:11β,21-二羟基-16α,17-[(1-甲基亚乙基)-二氧]孕甾-1,4-二烯-3,20-二酮[化学结构式][分子式]C24H32O6[分子量]416.51[性状]本品为白色乳膏。

[药理毒理]药理作用本品为糖皮质激素类药物，具有抗炎、抗过敏、止痒与减少渗出作用；可以减轻和防止组织对炎症的反应，能消除局部非感染性炎症引起的发热、发红与肿胀，从而减轻炎症的表现；具有防止或抑制细胞免疫反应、抑制初次免疫应答的免疫抑制作用。

倍他⽶松⽔杨酸软膏说明书信息（英国上市）Summary of Product Characteristics last updated on the eMC: 14/04/2011Diprosalic OintmentHertford Road, Hoddesdon, Hertfordshire, EN11 9BU1. NAME OF THE MEDICINAL PRODUCT2. QUALITATIVE AND QUANTITATIVE COMPOSITION3. PHARMACEUTICAL FORM4. CLINICAL PARTICULARS4.1 Therapeutic indications4.2 Posology and method of administrationDiprosalic OintmentBetamethasone Dipropionate 0.064% w/w*(* equivalent to 0.05% Betamethasone)Salicylic Acid 3.00% w/wOintmentBetamethasone Dipropionate is a synthetic fluorinated corticosteroid. It is active topically and produces a rapid and sustained response in those inflammatory dermatoses that are normally responsive to topicalcorticosteroid therapy, and it is also effective in the less responsive conditions, such as psoriasis of the scalp, chronic plaque psoriasis of the hands and feet, but excluding widespread plaque psoriasis.Topical salicylic acid softens keratin, loosens cornified epithelium and desquamates the epidermis.Diprosalic presentations are therefore indicated for the treatment of hyperkeratotic and dry corticosteroid-responsive dermatoses where the cornified epithelium may resist penetration of the steroid. The salicylic acid constituent of Diprosalic preparations, as a result of its descaling action, allows access of the dermis more rapidly than by applying steroid alone. Adults :Once to twice daily. In most cases a thin film should be applied to cover the affected area twice daily. For some patients adequate maintenance therapy may be achieved with less frequent application.It is recommended that Diprosalic preparations are prescribed for two weeks, and that treatment is reviewed at that time. The maximum weekly dose should not exceed 60g. Merck Sharp & Dohme Limited Telephone: +44 (0)1992 467 272Fax: +44 (0)1992 479 292Medical Information e-mail: medicalinformationuk@/doc/c5051a7002768e9951e7380e.htmlBefore you contact this company: often several companieswill market medicines with the same active ingredient. Pleasecheck that this is the correct company before contactingthem. Why?Dosage in children should be limited to 5 days.4.3 ContraindicationsRosacea, acne, perioral dermatitis, perianal and genital pruritus. Hypersensitivity to any of the ingredients of the Diprosalic presentations contra-indicates their use as does tuberculous and most viral lesions of the skin, particularly herpes simplex, vacinia, varicella. Diprosalic should not be used in napkin eruptions, fungal or bacterial skin infections without suitable concomitant anti-infective therapy.4.4 Special warnings and precautions for useOcclusion must not be used, since under these circumstances the keratolytic action of salicylic acid may lead to enhanced absorption of the steroid.Local and systemic toxicity is common, especially following long continuous use on large areas of damaged skin, in flexures or with polythene occlusion. If used in children or on the face courses should be limited to 5 days. Long term continuous therapy should be avoided in all patients irrespective of age.Topical corticosteroids may be hazardous in psoriasis for a number of reasons, including rebound relapses following development of tolerance, risk of generalised pustular psoriasis and local systemic toxicity due to impaired barrier function of the skin. Careful patient supervision is important.It is dangerous if Diprosalic presentations come into contact with the eyes. Avoid contact with the eyes and mucous membranes.The systemic absorption of betamethasone dipropionate and salicylic acid may be increased if extensive body surface areas or skin folds are treated for prolonged periods or with excessive amounts of steroids. Suitable precautions should be taken in these circumstances, particularly with infants and children.If irritation or sensitization develops with the use of Diprosalic Ointment and Lotion, treatment should be discontinued.Any side effects that are reported following systemic use of corticosteroids, including adrenal suppression, may also occur with topical corticosteroids, especially in infants and children.If excessive dryness or increased skin irritation develops, discontinue use of this preparation.Peadiatric Use: Peadiatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients because of greater absorption due to a large skin surface area to body weight ratio.HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels and absence of response to ACTH stimulation.Manifestations of intracranial hypertension include a bulging fontanelle, headaches and bilateral papilledema.4.5 Interaction with other medicinal products and other forms of interactionNone stated4.6 Pregnancy and lactationSince safety of topical corticosteroid use in pregnant women has not been established, drugs of this class should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus. Drugs of this class should not be used extensively in large amounts or for prolonged periods of time in pregnant patients.Since it is not known whether topical administration of corticosteroids can result in sufficient systemicabsorption to produce detectable quantities in breast milk, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.4.7 Effects on ability to drive and use machines4.8 Undesirable effectsDiprosalic skin preparations are generally well tolerated and side-effects are rare.Continuous application without interruption may result in local atrophy of the skin, striae and superficial vascular dilation, particularly on the face.Adverse reactions that have been reported with the use of topical corticosteroids include: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis and allergic contact dermatitis.The following may occur more frequently with the use of occlusive dressings: maceration of the skin,secondary infection, skin atrophy, striae and miliaria.In addition, prolonged use of salicylic acid preparations may cause dermatitis.4.9 OverdoseExcessive prolonged use of topical corticosteroids can suppress pituitary-adrenal functions resulting insecondary adrenal insufficiency, and produce manifestations of hypercorticism, including Cushing's disease.Treatment: Appropriate symptomatic treatment is indicated. Acute hypercorticoid symptoms are usually reversible. Treat electrolyte imbalance, if necessary. In case of chronic toxicity, slow withdrawal ofcorticosteroids is advised.With topical preparations containing salicylic acid excessive prolonged use may result in symptoms ofsalicyclism. Treatment is symptomatic. Measures should be taken to rid the body rapidly of salicylate.Adminster oral sodium bicarbonate to alkalinize the urine and force diuresis.The steroid content of each tube is so low as to have little or no toxic effect in the unlikely event of accidental oral ingestion.5. PHARMACOLOGICAL PROPERTIES5.1 Pharmacodynamic propertiesDiprosalic preparations contain the dipropionate ester of betamethasone which is a glucocorticoid exhibiting the general properties of corticosteroids, and salicylic acid which has keratolytic properties.Salicylic acid is applied topically in the treatment of hyperkeratotic and scaling conditions where its keratolytic action facilitates penetration of the corticosteroid.In pharmacological doses, corticosteroids are used primarily for their anti-inflammatory and/or immune suppressive effects.Topical corticosteroids such as betamethasone dipropionate are effective in the treatment of a range of dermatoses because of their anti-inflammatory, anti-pruritic and vasoconstrictive actions. However, while the physiologic, pharmacologic and clinical effects of the corticosteroids are well known, the exact mechanisms of their action in each disease are uncertain.5.2 Pharmacokinetic propertiesSalicylic acid exerts only local action after topical application.The extent of percutaneous absorption of topical corticosteroids is determined by many factors including vehicle, integrity of the epidermal barrier and the use of occlusive dressings.Topical corticosteroids can be absorbed through intact, normal skin. Inflammation and/or other disease processes in the skin may increase percutaneous absorption.Once absorbed through the skin, topical corticosteroids enter pharmacokinetic pathways similar tosystemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees, are metabolised primarily in the liver and excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted in the bile.5.3 Preclinical safety dataThere are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.6. PHARMACEUTICAL PARTICULARS6.1 List of excipientsLiquid ParaffinWhite Soft Paraffin6.2 IncompatibilitiesNone Stated.6.3 Shelf life60 months6.4 Special precautions for storageDo not store above 25°C.6.5 Nature and contents of container15, 30 or 100gm expoxy-lined aluminium tubes with plastic caps.6.6 Special precautions for disposal and other handlingNot applicable7. MARKETING AUTHORISATION HOLDERMerck Sharp & Dohme LimitedHertford RoadHoddesdonHertfordshireEN11 9BUUK8. MARKETING AUTHORISATION NUMBER(S)PL 00025/05709. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION10th June 1986 / 25th July 199710. DATE OF REVISION OF THE TEXT21 March 2011Prescription Only MedicineMerck Sharp & Dohme Limited 2011. All rights reserved. DIPROSALIC Ointment/UK/04-11/06。

解热镇痛类药品列表分类查看本药品列表被可按中成药和西药分类查看：解热镇痛类中成药物列表解热镇痛类西药列表解热镇痛类药品列表Axe Brand Universal Oil（斧标驱风油）祛风静痛，芳香通络。

用于伤风鼻塞，头痛肚痛，舟车晕浪，跌打扭伤，肌肉酸痛，蚊虫叮咬。

N-苯(基)乙酰胺一清颗粒清热泻火解毒，用于火毒血热所致的身热烦躁，目赤口疮，咽喉牙龈肿痛，大便秘结及咽炎、扁桃体炎、牙龈炎。

丁硼乳膏（雅皓）有消炎止痛作用。

适用于急慢性牙龈炎、口腔炎等引发的牙痛、牙龈出血、肿痛、溃疡、溢脓等病症。

丁细牙痛胶囊清热解毒，疏风静痛。

用于风火牙痛，症见：牙痛阵作，遇风即发，受热加重，甚那么齿痛连及头部脸部；或伴有牙龈肿胀，患处红、肿、热、痛，得凉痛减；或伴有口渴喜凉饮，便干溲黄，舌红或舍尖红，苔薄黄或苔白少津，脉浮数或脉弦。

急性牙髓炎、急性根尖周炎见上述病症者。

七制香附丸开郁顺气，调经养血。

用于月经错后，胸胁胀痛，小腹冷痛。

七叶皂苷二乙胺水杨酸凝胶用于挫伤、扭伤、压伤、血肿及腱鞘炎。

七叶莲片祛风除湿，活血止痛。

用于各类疼痛，风湿痹痛，神经痛,胃疼,跌打骨折，外伤出血。

万应胶囊清热，镇惊。

解毒；用于口舌生疮，牙龈、咽喉肿痛；小儿高热，烦躁易惊等。

万灵筋骨膏散风活血，舒筋定痛。

用于风寒湿邪，伤于筋骨，关节疼痛，四肢麻木，行动艰巨。

万痛筋骨贴本产品的基料为功能无纺布，医用胶为主体部份，以其为载体并利用胶体中所含的鹅掌柴油等植物精华成份而达到冷敷理疗，减缓头痛和增进康复等作用。

本产品有效减缓风寒湿痛.腰腿痛.跌打损伤.风湿及类风湿关节炎.骨质增生.腰椎间盘突出.颈椎病.坐骨神经痛.肩周炎等引发的疼痛，增进机体康复。

万通筋骨片祛风散寒，通络止痛。

用于痹症，肩周炎，颈椎病，腰腿痛，肌肉关节疼痛，屈伸不利，和风湿性关节炎、类风湿性关节炎见以上证候者。

三七伤药片舒筋活血，散瘀止痛。

用于跌打损伤，风湿瘀阻，关节痹痛;急慢性扭挫伤，神经痛见上述证候者。

复方克霉唑乳膏II(奥青)的说明书关于《复方克霉唑乳膏II(奥青)的说明书》，是我们特意为大家整理的，希望对大家有所帮助。

皮肤病是现如今各种多发率病症中的一种，应对皮肤疾病的多发率，我们应当采用如何的方式解决呢?棘籽克霉唑乳膏II(奥青)在治牛皮癣层面拥有明显的作用，也是历经很多年诊治经验获得验证的皮肤病药品，实际的我们能够看下面的详细介绍。

生产药品名称疫苗通用性名字：棘籽克霉唑乳膏(II)产品名称：棘籽克霉唑乳膏II(奥青)拼音字母全码：FuFangKeMeiZuoRuGaoII(AoQing)生产关键成分疫苗本产品主要成分为二丙酸倍他米松、克霉唑栓、盐酸青霉素。

1.二丙酸倍他米松化学名：16-羟基-11，17，21-三甲基-9-氟孕甾-1,4-二烯-3,20-二酮-17,21-二丙酸盐化学式：C28H37FO7相对分子质量：504.592.克霉唑栓化生产性状疫苗品为乳白色药膏，气芬芳，有清爽感。

生产适用范围/功效与作用疫苗适用对皮质类固醇药品比较敏感的皮肤炎症病症(如接触性皮炎、湿疹、神经性皮炎等继发性细菌和真菌感染)。

生产型号规格疫苗5g生产使用方法使用量疫苗每天二次，先将伤处清理。

将少量药膏擦抹伤处，随后轻轻地磨擦，使其充足渗透到皮肤。

为确保医治皮肤病种类的功效，服药治疗过程应是够，每一个治疗过程依据某些病人及浓淡状况而定或遵医师标示应用。

生产副作用疫苗1.应用棘籽克霉唑栓偶可产生的副作用包含：觉得出现异常、斑疹、水肿、继发性感染等。

2.应用克霉唑栓可能造成的副作用包含：红斑、刺疼、水疱、起屑、水肿、荨麻疹及皮肤刺激性反映。

3.部分应用皮质类固醇类药造成的副作用包含：灼热感、过敏痒疹、皮肤干、毛囊炎、多毛症、痤疮样皮疹、色素减退、口周炎、变应性接触性皮炎、皮肤侵润、继发性感染、皮肤萎缩纹及粟粒疹等。

4.少年儿童部分应用皮质类固醇类药现有造成中脑-脑垂体-肾上腺素(HPA)作用抑止、柯兴氏综合征、颅压高等副作用的报导。